Efficacy of Supplement Adjuvant Capecitabine in HR+/HER2- Breast Cancer Patients With High Risks

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Efficacy of Supplement Adjuvant Capecitabine in HR+/HER2- Breast Cancer Patients With High Risks	Neoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, neoplasm, skin disorder	Recruiting	Phase 3	2023-04-25		NCT05212454

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Second Affiliated Hospital, Zhejiang University, School of Medicine	561

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
the Second Affiliated Hospital of Zhejiang Univercity School of Medicine	Hanzhou	China	2

Clinical trials